July, 2017, Guara, Brasilia, Brazil. NSAI has been recognized by Brazil’s ANVISA regulatory authority and now is able to perform MDSAP quality management system assessments according to the announcement appearing in the Brazil Official News RE nº 1.783/2017.  Medical device manufacturers may now engage NSAI to assess their QMS in accordance with Brazilian Good Manufacturing Practices (BGMP) and MDSAP requirements applicable in the USA, Canada, Australia and Japan.

For more information on CRO Group services including company-wide MDSAP training, internal auditor MDSAP training, MDSAP consulting including establishing SOPs to meet regulatory requiremernts of the MDSAP countries including Australia, Brazil, Canada and Japan, and performing initial MDSAP Gap Analysis, MDSAP Planning, and MDSAP Preaudit, click here and select Auditing and Training, and mention MDSAP in the details.